Palvella Therapeutics, Inc. (PVLA)
123.46
+3.08
(+2.56%)
USD |
NASDAQ |
Apr 02, 16:00
123.21
-0.25
(-0.20%)
Pre-Market: 20:00
Palvella Therapeutics Total Assets (Quarterly) : 59.56M for Dec. 31, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Ligand Pharmaceuticals, Inc. | 1.561B |
| Gossamer Bio, Inc. | 172.25M |
| Agenus, Inc. | 226.80M |
| Novavax, Inc. | 1.183B |
| Regeneron Pharmaceuticals, Inc. | 40.56B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 31.58M |
| Shareholders Equity (Quarterly) | 27.98M |
| Debt to Equity Ratio | 0.6573 |
| Current Ratio | 5.200 |
| Net Debt Paydown Yield | -0.28% |